Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Safety and Tolerability of Intra-Venous Ascorbic Acid in Allogeneic Hematopoietic Cell Transplant Recipients: A Matched Historical Control Study

Gary Simmons, DO, Roy Sabo, PhD, Maja Radic, BS, May Aziz, Pharm.D, Kelly Hawks, Pharm.D, Robyn J Bernard, BS, Ali Jafri, BS, Catherine H Roberts, PhD, Ramesh Natarajan, Alpha Fowler, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-138543

Published: 2020

Journal Articles

Favorable Immune Reconstitution in Patients Administered Anti-Thymocyte Globulin (ATG) Early in the Course of Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation

Viktoriya Zelikson, BS, Natasha Raman, Anatevka Rebiero, MD, Elizabeth Krieger, MD, Catherine H Roberts, PhD, Gary Simmons, DO, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138581

Published: 2020

Journal Articles

FLT3 Internal Tandem Duplication Quantitation and Length Analysis By Digital PCR Paired with High-Speed AFM

Sean Koebley, PhD, Andrey Mikheikin, PhD, Kevin Leslie, PhD, Wendy McConnell-Wells, Joshua H Lehman, Daniel Guest, Taha Al Juhaishi, MD, Xiaojie Zhang, MD, Catherine H Roberts, PhD, Loren Picco, PhD, Amir Ahmed Toor, MD, Alden Chesney, MD, Jason Reed, PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-137096

Published: 2020

Journal Articles

Risk Stratified Tandem Vs Single Autologous Stem Cell Transplantation for Multiple Myeloma Yields Equivalent Survival

Kevin Sing, MD, Roy Sabo, PhD, James O'Bryan, Matthew Risendal, Catherine H Roberts, PhD, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-136800

Published: 2020

Journal Articles

Functional B Cell Reconstitution Following Allogeneic Stem Cell Transplantation

Thuy N. Ho, MD, Maheen Khan, MS, Bennett Clark, Elizabeth Krieger, MD, Catherine H Roberts, PhD, Amir Ahmed Toor, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-142799

Published: 2020

Journal Articles

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

Blood (2016) 127 (12): 1531–1538.

https://doi.org/10.1182/blood-2015-11-679407

Published: 2016

Includes: Supplemental data

Journal Articles

Exome Sequencing Derived Alloreactivity Potential May Predict Gvhd in Allogeneic Stem Cell Transplantation

Max Jameson-Lee, PhD, Allison F Scalora, MS, Vishal Koparde, PhD, David Jared Kobulnicky, MD, Badar Abdur Razzaq, BS, Andrea Ferreira-Gonzalez, PhD, Myrna G. Serrano, PhD, Catherine H. Roberts, PhD, Gregory Buck, PhD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 3078.

https://doi.org/10.1182/blood.V126.23.3078.3078

Published: 2015

Journal Articles

Peptides Derived from the CMV Proteome Mimic Unique Stem Cell Transplant Recipient Specific Peptides: Possible Role in Eliciting a Pro-Gvh T Cell Response

Charles E. Hall, MS, Max Jameson-Lee, PhD, Abdelrhman Elnasseh, Vishal Koparde, PhD, Allison F. Scalora, MS, Catherine H. Roberts, PhD, Nihar U. Sheth, MS, Myrna G. Serrano, PhD, Daniel Nixon, DO, PhD, Harold M. Chung, MD, Oveimar A. De la Cruz, MD, William B. Clark, MD, John M. McCarty, MD, Gregory A. Buck, PhD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 4285.

https://doi.org/10.1182/blood.V126.23.4285.4285

Published: 2015

Journal Articles

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

Gary Simmons, DO, Allison F. Scalora, MS, Roy T Sabo, PhD, Catherine H. Roberts, PhD, William B. Clark, MD, Harold M. Chung, MD, Amir A. Toor, MD, John M. McCarty, MD

Blood (2015) 126 (23): 5448.

https://doi.org/10.1182/blood.V126.23.5448.5448

Published: 2015

Journal Articles

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Ali S Shubar Ali, BS, Catherine H. Roberts, PhD, Allison F Scalora, MS, Kristen M Kobulnicky, MS, Shiyu Song, MDPhD, William B. Clark, MD, Harold M. Chung, MD, John M. McCarty, MD, Michael C. Neale, PhD, Amir A. Toor, MD

Blood (2015) 126 (23): 5467.

https://doi.org/10.1182/blood.V126.23.5467.5467

Published: 2015

Journal Articles

A Mathematical Model of Hematopoietic Stem Cell Transplantation and Analysis of the Effect of Drug Treatments on Transplantation in Patients with Lymphoma

Racheal L Cooper, MS, Allison F. Scalora, MS, Elaine Wang, MD, John M. McCarty, MD, Jennifer Anderson, RN, Catherine H. Roberts, PhD, Troy Lund, MD PhD, Amir A. Toor, MD, Angela Reynolds, PhD

Blood (2015) 126 (23): 2376.

https://doi.org/10.1182/blood.V126.23.2376.2376

Published: 2015

Journal Articles

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Radhika Thorn, MD, Jeremy Meier, BS, Elaine Wang, MD, Roy T Sabo, PhD, Allison F Scalora, MS, Catherine H Roberts, PhD, Shiyu Song, MD, PhD, Masoud H Manjili, DVM, PhD, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Amir A Toor, MD

Blood (2013) 122 (21): 4577.

https://doi.org/10.1182/blood.V122.21.4577.4577

Published: 2013

Journal Articles

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

David Jared Kobulnicky, MD, Roy T Sabo, PhD, Allison F Scalora, MS, David Portier, MD, Devon Fletcher, MD, Jeffrey M Tessier, MD, William B Clark, MD, Harold M Chung, MD, John M McCarty, MD, Catherine H Roberts, PhD, Amir A Toor, MD

Blood (2013) 122 (21): 2071.

https://doi.org/10.1182/blood.V122.21.2071.2071

Published: 2013

Journal Articles

Whole Exome Sequencing To Estimate Alloreactivity Potential Between Donors and Recipients In Stem Cell Transplantation

Juliana Sampson, PhD, Nihar Sheth, PhD, Vishal N Koparde, PhD, Allison Scalora, MS, Myrna G Serrano, PhD, Vladimir Lee, PhD, Maximillian Jamison-Lee, PhD, Andrea Ferreira-Gonzalez, PhD, Catherine H Roberts, PhD, Masoud H Manjili, DVM, PhD, Gregory Buck, PhD, Michael C Neale, PhD, Amir A Toor MD

Blood (2013) 122 (21): 150.

https://doi.org/10.1182/blood.V122.21.150.150

Published: 2013

Journal Articles

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Matthew Risendal, BS, Roy T Sabo, PhD, Allison F Hazlett, MS, Priscilla Mpasi, BS, Joan Bolling, William B Clark, MD, John M McCarty, MD, Harold M Chung, MD, Catherine H Roberts, PhD, Amir A Toor, MD

Blood (2012) 120 (21): 3123.

https://doi.org/10.1182/blood.V120.21.3123.3123

Published: 2012

Journal Articles

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Amir A Toor, MD, Roy T Sabo, PhD, Harold M Chung, MD, Catherine H Roberts, PhD, Rose H Manjili, BS, Shiyu Song, MD, PhD, David C. Williams, Jr., MD, PhD, William Clark, MD, Masoud H Manjili, DVM, PhD, John M McCarty, MD

Blood (2011) 118 (21): 3043.

https://doi.org/10.1182/blood.V118.21.3043.3043

Published: 2011

Journal Articles

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Amir A Toor, MD, Kyle Payne, BS, Harold M Chung, MD, Catherine H Roberts, PhD, Roy T Sabo, PhD, Maciej Kmieciak, PhD, William Clark, MD, Christy McLaughlin, BS, Angela Buskey, RN, Jennifer Anderson, RN, Rose H Manjili, BS, Susan D. Roseff, MD, John M McCarty, MD, Masoud H Manjili, DVM, PhD

Blood (2011) 118 (21): 2926.

https://doi.org/10.1182/blood.V118.21.2926.2926

Published: 2011

Journal Articles

Oligoclonal T Cells Associated with Gvhd Following Allogeneic Stem Cell Transplantation Conditioned with Thymoglobulin and Reduced Intensity Total Body Irradiation.

Masoud Manjili, PhD, Catherine H Roberts, PhD, Maciej Kmieciak, PhD, Madhu S Gowda, MD, MB, BS, Andrea Ferreira-Gonzalez, PhD, Kellie Archer, PhD, Shiyu Song, MD, Harold M Chung, MD, John M. McCarty, MD, Amir Toor, MD

Blood (2009) 114 (22): 4662.

https://doi.org/10.1182/blood.V114.22.4662.4662

Published: 2009

Journal Articles

Adequate Immune Reconstitution in Recipients of Unrelated Donor Hematopoietic Cell Transplants Given Rabbit Anti-Thymocyte Globulin During Conditioning.

Devon Fletcher, MD, John M. McCarty, MD, Harold M Chung, MD, Kathryn Candler, MA, Catherine H Roberts, PhD, Lisa Shickle, MS, Miriam Rabie, John Lamberta, FNP, Richard Edwards, PA-C;, MT, Amir Toor, MD

Blood (2009) 114 (22): 2234.

https://doi.org/10.1182/blood.V114.22.2234.2234

Published: 2009

Journal Articles

Familial protein S deficiency with a variant protein S molecule in plasma and platelets

HP Schwarz, MJ Heeb, R Lottenberg, H Roberts, JH Griffin

Blood (1989) 74 (1): 213–221.

https://doi.org/10.1182/blood.V74.1.213.213

Published: 1989

NARROW

Safety and Tolerability of Intra-Venous Ascorbic Acid in Allogeneic Hematopoietic Cell Transplant Recipients: A Matched Historical Control Study

Favorable Immune Reconstitution in Patients Administered Anti-Thymocyte Globulin (ATG) Early in the Course of Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation

FLT3 Internal Tandem Duplication Quantitation and Length Analysis By Digital PCR Paired with High-Speed AFM

Risk Stratified Tandem Vs Single Autologous Stem Cell Transplantation for Multiple Myeloma Yields Equivalent Survival

Functional B Cell Reconstitution Following Allogeneic Stem Cell Transplantation

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

Exome Sequencing Derived Alloreactivity Potential May Predict Gvhd in Allogeneic Stem Cell Transplantation

Peptides Derived from the CMV Proteome Mimic Unique Stem Cell Transplant Recipient Specific Peptides: Possible Role in Eliciting a Pro-Gvh T Cell Response

The Use of Biomarker Ferritin and Albumin As Well As HCT-CI, but Not PAM, Was Predictive of Suvival, Gvhd and, Relapse in Myeloid Malignancies

Lymphocyte Recovery Kinetics in Patients Undergoing Myeloablative Conditioning and Allogeneic Stem Cell Transplantation

A Mathematical Model of Hematopoietic Stem Cell Transplantation and Analysis of the Effect of Drug Treatments on Transplantation in Patients with Lymphoma

Favorable T Cell Reconstitution In Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation with Low-Dose Rabbit Anti-Thymocyte Globulin and Total Body Irradiation

Immune Reconstitution In Anti-Thymocyte Globulin Conditioned Unrelated Donor Stem Cell Transplantation

Whole Exome Sequencing To Estimate Alloreactivity Potential Between Donors and Recipients In Stem Cell Transplantation

Optimizing Outcomes in Multiple Myeloma Using Risk Stratified Allocation to Single Versus Tandem Autologous SCT.

Favorable Outcomes in Patients with High Donor-Derived T Cell Count Following In Vivo T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation

Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Oligoclonal T Cells Associated with Gvhd Following Allogeneic Stem Cell Transplantation Conditioned with Thymoglobulin and Reduced Intensity Total Body Irradiation.

Adequate Immune Reconstitution in Recipients of Unrelated Donor Hematopoietic Cell Transplants Given Rabbit Anti-Thymocyte Globulin During Conditioning.

Familial protein S deficiency with a variant protein S molecule in plasma and platelets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only